Health Care [ 3/12 ] | Health Care Equipment & Supplies [ 26/75 ]
NYSE | Common Stock
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.
It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services.
The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators.
It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process.
The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025.
Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 23, 26 | -4.88 Increased by +42.79% | -2.00 Decreased by -144.00% |
| Nov 7, 25 | -4.23 Increased by +82.56% | -1.94 Decreased by -118.04% |
| Aug 7, 25 | -3.81 Decreased by -328.09% | -2.00 Decreased by -90.50% |
| May 9, 25 | -4.38 Decreased by -427.71% | -0.04 Decreased by -10.85 K% |
| Feb 26, 25 | -8.53 Decreased by -21.23 K% | -0.33 Decreased by -2.46 K% |
| Nov 5, 24 | -24.25 Decreased by -60.52 K% | -0.34 Decreased by -7.03 K% |
| Aug 1, 24 | -0.89 Decreased by -1.38 K% | -0.06 Decreased by -1.38 K% |
| May 8, 24 | -0.83 Decreased by -6.48 K% | -0.05 Decreased by -1.56 K% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 246.55 M Increased by +6.21% | -80.57 M Increased by +41.60% | Decreased by -32.68% Increased by +45.01% |
| Sep 30, 25 | 245.96 M Increased by +6.71% | -69.75 M Increased by +82.18% | Decreased by -28.36% Increased by +83.30% |
| Jun 30, 25 | 241.57 M Increased by +3.47% | -62.64 M Increased by +89.14% | Decreased by -25.93% Increased by +89.50% |
| Mar 31, 25 | 231.33 M Decreased by -1.36% | -71.32 M Increased by +86.79% | Decreased by -30.83% Increased by +86.60% |
| Dec 31, 24 | 232.15 M Decreased by -4.91% | -137.97 M Decreased by -339.50% | Decreased by -59.43% Decreased by -362.20% |
| Sep 30, 24 | 230.50 M Decreased by -5.07% | -391.45 M Decreased by -1.52 K% | Decreased by -169.83% Decreased by -1.61 K% |
| Jun 30, 24 | 233.48 M Decreased by -1.90% | -576.73 M Decreased by -1.49 K% | Decreased by -247.02% Decreased by -1.52 K% |
| Mar 31, 24 | 234.51 M Decreased by -0.88% | -539.69 M Decreased by -258.32 K% | Decreased by -230.14% Decreased by -260.62 K% |